The session. High intraday high russell 2000 continues its high but it, too, has faded during the session. The russell flat, the other indices negative coming up in todays show, well ask allianz chief economic adviser Mohamed El Erian about todays highs plus, the president of shopify about the companys new partnership with alipay mike santoli, tracking the market action. Meg tirrell has more news on pfi zechlt rs vaccine data and phil lebeau, covering the boeing 747 max. Mike, start us off here. Weve been dealing with a couple of issues, the market being a little stretched on the upside after that strong rally month to date. Over bullish sentiment has had a hard time getting traction, but no damage done at this point on the year to date chart were slightly above that september high by half a percent nothing damaging really happening here i wanted to zoom into the last ten days of trading or basically really more like eight days of trading, back to last monday, week ago monday. Pfizer n
The only stocks that are doing well right now, some of the reopening trades and some of the big laggers for the year like cruises and airlines and some retailers still in the Green Energy Stocks also outperforming. Is this the start of a serious correction or a buy the dip opportunity were diving into that debate. 59 minutes left of trade 59 minutes of of this roller coaster session. Lots of guests as well the market pulls back. Well speak with three ceos that got insight into the state of the consumer, their spending and recovery in america. The ceo of campbells soup will join us on the back of had his companys Earnings Results that stock down 7 right now plus, well get two reeds on the beaten down travel sector with glenn fogel and mark hopelinger. Well speak with nick clegg about the new policies surrounding the election looking forward to that one. Lets get straight to our top story of the day the market selloff Mike Santelli has more on the major market pull back. A big pluflush o
Company ipo in a year, if approved by President Trump. Is this ride hailer. Eeking to shore up cash haidi lets look at how we are setting up for the final trading session of the week in asia. After a pretty lackluster session, we had u. S. Stocks passing some of those parsing some of those losses, still dropping for a second day but finding support after bouncing off the 50 Day Moving Average on the s p. S p futures seeing a little positivity on the u. S. Fridays session, about 0. 2 higher. Tax leading the client is apple, facebook and peppe microsoft are weighing on declines. We saw a Little Movement in treasuries as well. In asia, the nikkei 225 is seeing an upside, 0. 1 when it comes to futures trading in chicago at the moment. Dollar weakness yen strength will be an issue, the. We have the yen appreciated to the strongest level in six months across broad dollar weakness. The u. S. Dollar index falling for a fifth straight session. We are also keeping watch on the dollar and how it
Are miles apart. We are focused on that potential record close on the s p 500. The number youre watching for is 3386. 15, a couple points off of it as we stand, sara. Hard to believe that we are here coming up on todays show. S p 500 could close at a record high for the First Time Since mid february were going to talk to wharton professor Jeremy Siegel about whether the rally can last from here. Plus counting down to a pair of key Earnings Results after the bell, lyft and cisco gearing up to report well bring numbers and analysis as soon as they hit. Lets focus on the stories were watching with one hour left of trade. Mark santoli with the action, colin rush from oppenheimer. Lets start off with the broader market, familiar things taking us higher, tech, lower treasury yields and the like. Thats right. A bit of a reform to norm. Yesterday 3381 of about the late selloff. Of course were a couple points above that right now its kind of tantalizing also seems a little bit silly this hesita
Something positive, right, with that rising case count hitting new records, it seems virtually every day, and deaths also starting to move up in knows hardhit states as well with hospitalizations thats certainly been a focus for Market Participants as you guys well know Scott Gottlieb who we follow closely tweeting about the remdesivir news, very encouraged but needs to be confirmed in a prospective trial, appears to be a receipt peck testify analysis of the face three data suggesting a survival benefit in severe Covid Patients. We have made the point many times it is only good news on remdesivir, but lets remember its an infused therapy in the hospital typically for people who are severely ill what we are hoping for and waiting for are significant antivirals that will have an affect on the virus far earlier in its course so that people will feel much more comfortable in resuming behavior because if they were to get it and these were to be available they could immediately take an oral